Showing results (211-220 of 225) with videos related to
Sort By:
Pageof 23
Scientific Reports|July 9, 2016
Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virusShun Kaneko, Sei Kakinuma, Yasuhiro Asahina, et al.Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 10, 2025
A feasibility study for personalized phage therapy against drug-resistant bacteria in JapanKayoko Hayakawa, Kotaro Kiga, Shinjiro Ojima, et al.PNAS Nexus|June 10, 2025
Development of a nonreplicative phage-based DNA delivery system and its application to antimicrobial therapiesKotaro Kiga, Yusuke Sato'o, Xin-Ee Tan, et al.Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2023
Hepatocellular organellar abnormalities following elimination of hepatitis C virusHaruyo Aoyagi, Hiroko Iijima, Eman S Gaber, et al.Plos Computational Biology|January 9, 2025
Prediction of cccDNA dynamics in hepatitis B patients by a combination of serum surrogate markersKwang Su Kim, Masashi Iwamoto, Kosaku Kitagawa, et al.Nature Communications|March 13, 2021
Circadian control of hepatitis B virus replicationXiaodong Zhuang, Donall Forde, Senko Tsukuda, et al.Nature|May 17, 2022
Structural insights into the HBV receptor and bile acid transporter NTCPJae-Hyun Park, Masashi Iwamoto, Ji-Hye Yun, et al.The Journal of Infectious Diseases|March 9, 2023
Potential Anti-Mpox Virus Activity of Atovaquone, Mefloquine, and Molnupiravir, and Their Potential Use as TreatmentsDaisuke Akazawa, Hirofumi Ohashi, Takayuki Hishiki, et al.Iscience|April 5, 2021
Potential anti-COVID-19 agents, cepharanthine and nelfinavir, and their usage for combination treatmentHirofumi Ohashi, Koichi Watashi, Wakana Saso, et al.Cell Reports|April 14, 2021
Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cellsPeter A C Wing, Thomas P Keeley, Xiaodong Zhuang, et al.Pageof 23